Found 30 matching trials
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes PHASE3 The objective of the study is to investigate the efficacy, safety and toler...
Show More Location
1275.10.01019 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA) N/A GIOIA represents a multicenter pragmatic prospective cohort study, aimed at...
Show More Learn More & Join Trial
Cognitive Protective Effect of Newer Antidiabetic Drugs N/A The proposed study aims to:
1. Explore the cognitive protective effects of...
Show More Location
Alexandria University
Learn More & Join Trial
GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial PHASE4 Three SGLT2i were commercially available in Italy at the time the trial was...
Show More Location
Multiple Locations
Learn More & Join Trial
This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood PHASE1 To establish the bioequivalence of one fixed dose combination (FDC) tablet ...
Show More Location
Humanpharmakologisches Zentrum Biberach
Learn More & Join Trial
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh PHASE4 The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Show More Location
BIRDEM General Hospital
Learn More & Join Trial
Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology PHASE4 The primary aim of this exploratory mechanistic study is to investigate the...
Show More Location
Profil Mainz GmbH & Co. KG
Learn More & Join Trial
The Efficacy and Safety of Empagliflozin - Linagliptin and Empagliflozin- Metformin Therapy in Reduction of Body Weight in Type 2 Diabetic Patients . PHASE4 The goal of this clinical trial is - Comparison of Empagliflozin - Linaglip...
Show More Location
Bahria University
Learn More & Join Trial
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes NA This is an investigator-led prospective, randomized, open label, parallel s...
Show More Location
Department of Endocrinology, Changzhou No.2 People's Hospital, the Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study N/A To perform an observational analysis to emulate a target trial (i.e., a hyp...
Show More Status
Active Not Recruiting
Location
Brigham and Women's Hospital
Learn More & Join Trial